Predictors for operative mortality (OM) were studied in 172 consecutive patients (pts) undergoing coronary artery grafts (CAG) for angina pectoris.
INTRODUCTION
Coronary artery bypass surgery is now a widely used approach to the treatment of arteriosclerotic heart disease in selected patients. A few studies have suggested short-term relief of angina [1] [2] [3] and an increase in longevity [4] . Further follow-up is necessary before the effects of the operation can fully be evaluated.
In this report we present an analysis of clinical, anatomic, hemodynamic and operative factors affecting operative mortality in 172 consecutive patients. These patients underwent cardiac catheterization and coronary artery bypass grafts without associated surgical procedures at Yale-New Haven Hospital from July 1974 to June 1975. Data on each patient were prospectively collected and analyzed to identify those preoperative factors which could predict the immediate outcome of individual patients.
Coronary artery lesions of greater than 70 percent obstruction were classified as significant. Coronary artery disease was recorded as one, two or three vessel disease. Left main coronary artery disease (LMCD) was considered equivalent to disease of the proximal left anterior descending artery and proximal left circumflex artery. Diffuse disease of a coronary artery was determined by the presence of several lesions with greater than one cm in length and more than 70 percent narrowing of the arterial lumen. The right anterior oblique left ventriculogram was analyzed for calculation of ejection fraction according to the method of Greene [5] , and for the presence of mitral regurgitation.
Coronary artery surgery was performed within three weeks following cardiac catheterization in all patients. In one group of patients, no propranolol therapy was used preoperatively; in a second group, propranolol doses were gradually decreased (during a mean period of three days) and finally discontinued 24 hours prior to surgery; and in a third group, propranolol was abruptly discontinued 24 hours before surgery. Coronary artery bypass grafts were performed using saphenous veins to graft the posterior descending artery and marginal branch of the left circumflex coronary artery. The left internal mammary artery was used whenever possible to graft the left anterior descending artery. Dissection of the internal mammary arteries from the chest wall and proximal anastomoses of saphenous vein grafts were both accomplished without cardiopulmonary bypass. Sidebiting clamps were employed for proximal anastomoses of saphenous vein to the aorta. Distal anastomoses were done on full cardiopulmonary bypass with the heart in ventricular fibrillation; aortic cross-clamping was used only when a dry field could not be obtained by local occlusion of the coronary artery. Revascularization was considered "incomplete" ifgrafts were not placed in every diseased coronary branch. For the purpose of this study, operative mortality was defined as death occurring up to six weeks after surgery was performed. The period of six weeks was selected because it appeared to be the natural cut-off point between early and late mortality.
Statistical Methods
Contingency table chi-square (X2) [6] Table 3 . Finally, patients whose CPB time was longer than 120 mlnutes showed a mortality of 50 percent, a figure which is significantly higher than that of patients with CPB time shorter than 120 minutes ( history of ischemic heart disease, hypertension, obesity, smoking habits, previous myocardial infarction, congestive heart failure, heart size, left ventricular end-diastolic pressure, ejection fraction, or mitral regurgitation, or number of diseased vessels (except for left main coronary artery disease). In addition, this analysis of operative factors indicated that neither the number of grafts nor the completeness of revascularization had any effect upon operative mortality. In order to better predict operative mortality in individual patients, combinations of risk factors were also examined. Two combinations appeared to be associated with a significantly higher operative mortality: CPB time longer than 120 minutes and LMCD; and CPB time greater than 120 minutes and angina pectoris IV (Fig. 1) [4, [8] [9] [10] [11] [12] .
Four factors were found to be significantly associated with operative mortality: (1) angina pectoris Class IV NYHA; (2) abrupt propranolol withdrawal 24 hours prior to surgery; (3) left main coronary artery disease; and (4) cardiopulmonary bypass time longer than 120 minutes. The operative risk for individual patients with angina Class IV was four times greater than those patients with functionally less severe angina. Reports on the significance of severity ofangina symptoms are conflicting; some authors report that severity of angina is a very important risk factor, while others do not find that severe angina significantly increases operative mortality [15] [16] [17] [18] [19] [20] [21] [22] [23] . It must be pointed out, that objective measurements of angina pectoris severity are not available; and this fact may explain in part the lack of agreement in the findings of different medical centers. Furthermore, medical therapy with beta blocking agents may change the functional classification for angina pectoris in individual patients. However, it is not clear that all published series are comparable concerning the use ofbeta blocking agents. Ourpatients were on optimal medical management at the time that they were classified according to their angina symptoms.
In the 106 patients in whom propranolol was withdrawn abruptly 24 hours prior to surgery, the mortality was 6.6 percent (7/106); while in the 41 patients in whom propranolol doses were gradually reduced over an average of three days and then finally discontinued 24 hours before surgery, the operative mortality was 2.4 percent [1/41 (p < 0.05)]. In the 25 patients in whom propranolol was not used at all preoperatively, the operative mortality was 4.0 percent (1/25). Seven patients died in the abrupt propranolol withdrawal group: six after sustaining a myocardial infarction (first postoperative week), and one after a cerebrovascular accident (first postoperative week). One patient died in the gradual propranolol withdrawal group due to non-cardiac cause (bleeding peptic ulcer, fourth postoperative week). One patient died in the group which did not receive propranolol before surgery (sudden ventricular fibrillation, sixth postoperative week). A number of observers have recently reported that in some patients with severe coronary artery disease symptoms, abrupt propranolol withdrawal can cause rebound angina and even fatal myocardial infarction [24] [25] [26] [27] [28] . These observations are, to date, anecdotal and controlled studies have not been reported. However, if the discontinuation of propranolol were responsible for the induction of myocardial infarction, a role for the drug in the prevention of myocardial necrosis in patients with coronary artery disease might be implied. Myocardial infarction as complication of sudden propranolol withdrawal appears to be related to a diminished drug effect which leaves the myocardium suddenly unprotected against stress, rather than to residual pharmacological effects of the drug [29] . However, because the drug is known to have a depressive action upon myocardial contractility, some authors have stressed that it should be discontinued [30] before anticipated myocardial revascularization to avoid increased morbidity and mortality in the early postoperative period. Our observations clearly indicate that abrupt withdrawal of propranolol increased the risk for coronary bypass grafting by a factor of two. Patients in whom propranolol therapy was suddenly withdrawn were chosen, depending upon the clinical preferences of the referring physician. In addition, they did not differ significantly with respect to known clinical, anatomic, or operative descriptors.
Left main coronary artery disease (LMCD) has been associated in several other studies with increased operative mortality in coronary artery bypass grafting [9, 15, [31] [32] [33] . The mortality of 25 percent for patients with LMCD observed in this study compares with that reported by several series [9, 15, [31] [32] [33] . The number of diseased coronary vessels were not associated with a higher mortality. However, patients with left main coronary disease had higher operative mortality than those patients without left main coronary disease; suggesting that the severity of coronary disease may, indeed, play an important role in operative mortality.
The other factor found to affect operative mortality was duration of cardiopulmonary bypass (Table 4 (Fig. 1) . The combination of angina pectoris Class IV and CBP time longer than 120 minutes showed a mortality of 70 percent; and when angina was less severe than Class IV and the CBP time was under 120 minutes, the mortality was only 1.1 percent (Fig. 1) . These findings suggest, again, that the severity and extent of coronary artery disease and its clinical presentation, mainly severity and extent of angina pectoris, are the most important determinants of operative mortality.
Clinical Implications
Our data suggest the following clinical conclusions. First, patients on full medical therapy with angina pectoris Class IV NYHA are at four times greater risk for coronary bypass surgery. If these patients require a prolonged cardiopulmonary bypass time during cardiac surgery, their risk increases over fifty times. In this study, the prolonged cardiopulmonary bypass time was usually attributed to the presence of diffuse disease of the grafted vessel or vessels. Second, patients with LMCD are 10 times at greater risk than those without LMCD. If the CPB time for these patients during surgery extends longer than 120 minutes, their risk increases significantly.
Finally, abrupt propranolol withdrawal appears to play a very important role in operative mortality. Patients in whom propranolol therapy was stopped suddenly showed a significantly higher mortality than those patients in whom propranolol was gradually tapered and finally discontinued 24 hours before surgery.
